CRUZAIN INHIBITED BY BENZOYL-TYROSINE-ALANINE-FLUOROMETHYLKETONE
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
CRUZAIN INHIBITED BY BENZOYL-TYROSINE-ALANINE-FLUOROMETHYLKETONE
应用场景：
创建时间：
2024-10-23
相关数据集
Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure–Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments
Neglected tropical diseases (NTDs) make up a diverse group of debilitating illnesses disproportionately affecting impoverished communities in tropical and subtropical regions. Despite their significan
NIAID Data Ecosystem100
Raw data and analysis of venom solenopsins paper
Raw RData object file containing all numeric raw data and figures behind the manuscript "Venom alkaloids against Chagas disease parasite: search for effective therapies" published by Nature Scientific
Figshare2020-06-10 更新60
Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and Trypanosoma cruzi Cruzain
Gallinamide A, originally isolated with a modest antimalarial activity, was subsequently reisolated and characterized as a potent, selective, and irreversible inhibitor of the human cysteine protease
NIAID Data Ecosystem50
DataSheet_1_Broadening the spectrum of ivermectin: Its effect on Trypanosoma cruzi and related trypanosomatids.docx
Chagas disease is an endemic American parasitosis, caused by Trypanosoma cruzi. The current therapies, benznidazole (BZN) and nifurtimox (NFX), show limited efficacy and multiple side effects. Thus, t
NIAID Data Ecosystem70
In Vitro and in Vivo Anti- Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives
Chagas disease is a neglected tropical disease with 6–7 million people infected worldwide, and there is no effective treatment. Therefore, there is an urgent need to continue researching in order to d
NIAID Data Ecosystem50
